Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 5.

Heinzerling, Lucie; Ascierto, Paolo A; Dummer, Reinhard; Gogas, Helen; Grob, Jean-Jacques; Lebbe, Celeste; Long, Georgina V; McArthur, Grant; Moslehi, Javid J; Neilan, Tomas G; Ribas, Antoni; Robert, Caroline; Schadendorf, Dirk; Wolchok, Jedd D; Hauschild, Axel (2019). Adverse events 2.0-Let us get SERIOs: New reporting for adverse event outcomes needed in the era of immunooncology. European Journal of Cancer, 112:29-31.

Moreira, Alvaro; Loquai, Carmen; Pföhler, Claudia; Kähler, Katharina C; Knauss, Samuel; Heppt, Markus V; Gutzmer, Ralf; Dimitriou, Florentia; Meier, Friedegund; Mitzel-Rink, Heidrun; Schuler, Gerold; Terheyden, Patrick; Thoms, Kai-Martin; Türk, Matthias; Dummer, Reinhard; Zimmer, Lisa; Schröder, Rolf; Heinzerling, Lucie (2018). Myositis and neuromuscular side-effects induced by immune checkpoint inhibitors. European Journal of Cancer, 106:12-23.

Kirchberger, Michael Constantin; Ugurel, Selma; Mangana, Johanna; Heppt, Markus Valentin; Eigentler, Thomas Kurt; Berking, Carola; Schadendorf, Dirk; Schuler, Gerold; Dummer, Reinhard; Heinzerling, Lucie (2018). MEK inhibition may increase survival of NRAS-mutated melanoma patients treated with checkpoint blockade: Results of a retrospective multicentre analysis of 364 patients. European Journal of Cancer, 98:10-16.

Offenmueller, Sonja; Leiter, Ulrike; Bernbeck, Benedikt; Garbe, Claus; Eigentler, Thomas; Borkhardt, Arndt; Friedrich Classen, Carl; Corbacioglu, Selim; Dirksen, Uta; Ebetsberger-Dachs, Georg; Heinzerling, Lucie; Jorch, Norbert; Kuhlen, Michaela; Lawlor, Jennifer; Niggli, Felix; Streiter, Monika; Schneider, Dominik T; Brecht, Ines (2017). Clinical characteristics and outcome of 60 pediatric patients with malignant melanoma registered with the German Pediatric Rare Tumor Registry (STEP). Klinische Pädiatrie, 229(6):322-328.

Zimmer, Lisa; Apuri, Susmitha; Eroglu, Zeynep; Kottschade, Lisa A; Forschner, Andrea; Gutzmer, Ralf; Schlaak, Max; Heinzerling, Lucie; Krackhardt, Angela M; Loquai, Carmen; Markovic, Svetomir N; Joseph, Richard W; Markey, Kelly; Utikal, Jochen S; Weishaupt, Carsten; Goldinger, Simone M; Sondak, Vernon K; Zager, Jonathan S; Schadendorf, Dirk; Khushalani, Nikhil I (2017). Ipilimumab alone or in combination with nivolumab after progression on anti-PD-1 therapy in advanced melanoma. European Journal of Cancer, 75:47-55.

This list was generated on Sun Jun 16 01:33:31 2019 CEST.